Dashenlin Pharm Grp Co Ltd (603233) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.096x

Based on the latest financial reports, Dashenlin Pharm Grp Co Ltd (603233) has a cash flow conversion efficiency ratio of 0.096x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥818.72 Million ≈ $119.80 Million USD) by net assets (CN¥8.49 Billion ≈ $1.24 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Dashenlin Pharm Grp Co Ltd balance sheet quality to measure how much of total assets are equity-financed.

Dashenlin Pharm Grp Co Ltd - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Dashenlin Pharm Grp Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 603233 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.

Dashenlin Pharm Grp Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dashenlin Pharm Grp Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
SL Green Realty Corp NYSE:SLG	0.019x
Piramal Pharma Limited NSE:PPLPHARMA	0.109x
Shanghai V-Test Semiconductor Tech Co. Ltd. A SHG:688372	N/A
Neuland Laboratories Limited NSE:NEULANDLAB	-0.020x
Elmos Semiconductor SE F:ELG	0.017x
Zhejiang Huazheng New Material SHG:603186	0.086x
Fortuna Silver Mines Inc TO:FVI	0.066x
Procter & Gamble Hygiene and Health Care Limited NSE:PGHH	0.688x

Annual Cash Flow Conversion Efficiency for Dashenlin Pharm Grp Co Ltd (2012–2025)

The table below shows the annual cash flow conversion efficiency of Dashenlin Pharm Grp Co Ltd from 2012 to 2025. For the full company profile with market capitalisation and key ratios, see Dashenlin Pharm Grp Co Ltd (603233) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.66 Billion ≈ $1.27 Billion	CN¥5.35 Billion ≈ $782.90 Million	0.618x	+61.83%
2024-12-31	CN¥8.14 Billion ≈ $1.19 Billion	CN¥3.11 Billion ≈ $454.55 Million	0.382x	-4.60%
2023-12-31	CN¥7.93 Billion ≈ $1.16 Billion	CN¥3.17 Billion ≈ $464.43 Million	0.400x	-26.90%
2022-12-31	CN¥6.86 Billion ≈ $1.00 Billion	CN¥3.76 Billion ≈ $549.70 Million	0.547x	+108.91%
2021-12-31	CN¥5.94 Billion ≈ $868.61 Million	CN¥1.55 Billion ≈ $227.54 Million	0.262x	-25.28%
2020-12-31	CN¥5.57 Billion ≈ $815.49 Million	CN¥1.95 Billion ≈ $285.92 Million	0.351x	-11.07%
2019-12-31	CN¥4.33 Billion ≈ $633.86 Million	CN¥1.71 Billion ≈ $249.90 Million	0.394x	+39.29%
2018-12-31	CN¥3.09 Billion ≈ $451.68 Million	CN¥873.64 Million ≈ $127.84 Million	0.283x	+23.87%
2017-12-31	CN¥2.80 Billion ≈ $410.12 Million	CN¥640.39 Million ≈ $93.71 Million	0.228x	-38.12%
2016-12-31	CN¥1.34 Billion ≈ $196.39 Million	CN¥495.60 Million ≈ $72.52 Million	0.369x	-19.52%
2015-12-31	CN¥1.02 Billion ≈ $149.43 Million	CN¥468.59 Million ≈ $68.57 Million	0.459x	-41.20%
2014-12-31	CN¥574.85 Million ≈ $84.12 Million	CN¥448.58 Million ≈ $65.64 Million	0.780x	+59.72%
2013-12-31	CN¥589.93 Million ≈ $86.32 Million	CN¥288.22 Million ≈ $42.18 Million	0.489x	-35.64%
2012-12-31	CN¥381.11 Million ≈ $55.77 Million	CN¥289.31 Million ≈ $42.34 Million	0.759x	--

About Dashenlin Pharm Grp Co Ltd

SHG:603233 China Pharmaceutical Retailers

Market Cap

$2.98 Billion

CN¥20.40 Billion CNY

Market Cap Rank

#4915 Global

#833 in China

Share Price

CN¥17.91

Change (1 day)

-1.92%

52-Week Range

CN¥14.80 - CN¥21.27

All Time High

CN¥57.53